Arts

Books

Fashion & Beauty

Performing Arts

Food

Visual Arts

Design

Business

Entrepreneurship

Investing

Marketing

Careers

Management

Non-Profit

Comedy

Stand-Up

Comedy Interviews

Improv

Education

Self-Improvement

How To

Courses

Language Learning

Fiction

Comedy Fiction

Drama

Science Fiction

Government

Health & Fitness

Medicine

Alternative Health

Nutrition

Mental Health

Fitness

Sexuality

History

Kids & Family

Parenting

Stories for Kids

Education for Kids

Pets & Animals

Leisure

Video Games

Games

Automotive

Animation & Manga

Hobbies

Aviation

Home & Garden

Crafts

Music

Music Commentary

Music Interviews

Music History

News

Sports News

Entertainment News

News Commentary

Politics

Daily News

Business News

Tech News

Religion & Spirituality

Christianity

Spirituality

Religion

Judaism

Islam

Buddhism

Hinduism

Science

Social Sciences

Life Sciences

Natural Sciences

Nature

Chemistry

Mathematics

Earth Sciences

Physics

Astronomy

Society & Culture

Documentary

Relationships

Philosophy

Personal Journals

Places & Travel

Sports

Golf

Soccer

Wrestling

Basketball

Football

Fantasy Sports

Baseball

Wilderness

Running

Hockey

Rugby

Cricket

Volleyball

Tennis

Swimming

Technology

True Crime

TV & Film

Film Interviews

TV Reviews

After Shows

Film Reviews

Film History

Novidades da química e ciências, temas do cotidiano, bate-papo descontraído, conversas sobre experiências na vida acadêmica.

Química do dia a dia e divulgação científica, você encontra aqui!

Dúvides, sugestões e caneladas através do e-mail: oquimicast@gmail.com

Chave PIX para apoiar o projeto: quimicastpix@gmail.com

Novidades da química e ciências, temas do cotidiano, bate-papo descontraído, conversas sobre experiências na vida acadêmica. Química do dia a dia e divulgação científica, você encontra aqui! Dúvides, sugestões e caneladas através do e-mail: oquimicast@gmail.com Chave PIX para apoiar o projeto: quimicastpix@gmail.com

QuimiCast

Consigli, approfondimenti e peripezie di una farmacista digitale.

Pillole di Alice Pharmacist

Welcome to the EC Podcast!

In this new season, we will be discussing the latest developments, challenges and trends in the international coatings industry. 
We will be joined by international experts who will discuss these topics from within our sector.

A new episode will be released on the second Wednesday of every month, and additional content will be posted throughout the season! Follow and subscribe to the podcast to stay up to date! (It's free!)

Link to our main Website: https://www.european-coatings.com/

Welcome to the EC Podcast! In this new season, we will be discussing the latest developments, challenges and trends in the international coatings industry. We will be joined by international experts who will discuss these topics from within our sector. A new episode will be released on the second Wednesday of every month, and additional content will be posted throughout the season! Follow and subscribe to the podcast to stay up to date! (It's free!) Link to our main Website: https://www.european-coatings.com/

European Coatings Podcast

Informar a las personas sobre las Energías renovables

Las Energías renovables

Agracity Crop and Nutrition Ltd.

Vše o alchymii a chemii - lidech, místech a historii
All about alchemy and chemistry - people, places and history

Vše o alchymii a chemii - lidech, místech a historii All about alchemy and chemistry - people, places and history

Alchemy

AG (aka Prof Anas Ghadouani) and Dr. Liah Coggins bring you a series that dives into the many aspects of water, unravelling the mysteries, and taking you on journey that may surprise you. Where does the water that flows from your taps actually come from? Where does it go after it flows down the drain? What's purple water? Can you really drink wastewater? And why should you even care about any of this? Go behind the bill and discover the answers to all these questions and a million more you didn't know you had. New episodes (Fridays?).

Water You on About?

Podcast ini adalah podcast official dari HMPS Pendidikan Kimia UIN Jakarta, yang dikelola oleh departemen Kominfo. Salam baik! #Kompod

KOMPOD!

Question everything. Pokládáme otázky, o kterých se mlčí. Zajímá nás význam a důvod. Ptáme se proč. A jdeme hluboko.

Question everything. Pokládáme otázky, o kterých se mlčí. Zajímá nás význam a důvod. Ptáme se proč. A jdeme hluboko.

Podcast číslo 8

Hey lovelies out there! If you are advancing towards your class 12 boards or preparing for JEE MAINS and NEET , this podcast is for you!!
Padhle beta kyuki thori padhai bhi jaroori h! 
Being myself an aspirant I excatly know where to start from, where to end , what are the important points and what is to be focused on! It would be easier for you to revise along with your side hustle. The topics are discussed chapter wise and the important questions in QNA . 
You know You Need Me!♡

Hey lovelies out there! If you are advancing towards your class 12 boards or preparing for JEE MAINS and NEET , this podcast is for you!! Padhle beta kyuki thori padhai bhi jaroori h! Being myself an aspirant I excatly know where to start from, where to end , what are the important points and what is to be focused on! It would be easier for you to revise along with your side hustle. The topics are discussed chapter wise and the important questions in QNA . You know You Need Me!♡

Padhle Beta!!

TEMA DUREZA

Obrolan santai para chemist seputar bedah profesi, sharing wirausaha, kata milenials, dan yang gak kalah penting: ngacapruk!

Tayang setiap Jumat jam 7 malam untuk warga chemceman, alias chemilan cepuluh mania.

Obrolan santai para chemist seputar bedah profesi, sharing wirausaha, kata milenials, dan yang gak kalah penting: ngacapruk! Tayang setiap Jumat jam 7 malam untuk warga chemceman, alias chemilan cepuluh mania.

Chemilan Cepuluh

Podcast composto por cinco colegas com o intuito de trazer características químicas da composição da crosta terrestre seus minérios, tipos de rocha, solo e degradação do mesmo! UFFS REALEZA CURSO DE QUÍMICA

A Composição Da Crosta Terrestre

This podcast is a general guideline for information and not a specific tutorial for any specific syllabus; therefore, it should not be relied upon. StudySquare Ltd and any people involved in producing this podcast take no responsibility or liability for any potential errors or omissions regarding this podcast and make no guarantees of any completeness, accuracy, or usefulness of the information contained in this podcast, its structure or its show notes.

A-level Chemistry Revision with Jonas

Welcome to the Calix Podcast Series INNOVATING FOR THE EARTH, with innovation expert and radio and TV presenter James O’Loghlin.

Calix Podcast INNOVATING FOR THE EARTH

MDMA (3,4-methylenedioxymethamphetamine), known commonly as Ecstasy or Molly, has transitioned from a popular recreational drug to a promising therapeutic tool. The unique psychoactive properties of MDMA, which enhance empathy and reduce fear, have made it a powerful aid in psychotherapy, particularly for treating severe psychological conditions like PTSD. This article delves into the historical context, mechanism of action, therapeutic applications, clinical trials, safety considerations, and future prospects of MDMA in therapeutic settings. MDMA has a fascinating history that spans over a century. It was first synthesized by the German pharmaceutical company Merck in 1912 as part of their research into blood-clotting medications. However, the psychoactive properties of MDMA remained unknown for decades. It wasn't until the 1970s that American chemist Alexander Shulgin re-synthesized MDMA in his lab. Shulgin, known for his pioneering work in psychedelic chemistry, recognized the unique effects of MDMA on the human psyche. Shulgin shared his findings with psychotherapist Leo Zeff, who saw the potential of MDMA as a therapeutic aid. Zeff introduced MDMA to the psychotherapy community, where it quickly gained popularity as a tool for facilitating emotional breakthroughs and enhancing the therapeutic alliance. Throughout the late 1970s and early 1980s, MDMA was used by a network of therapists who believed in its ability to catalyze healing. However, MDMA's rising popularity extended beyond therapeutic circles. It became a sought-after recreational drug, particularly in the rave and club scene. The increasing non-medical use of MDMA led to concerns about its potential for abuse and neurotoxicity. In 1985, the U.S. Drug Enforcement Administration (DEA) stepped in and classified MDMA as a Schedule I controlled substance. This classification placed severe restrictions on the legal use of MDMA, effectively halting its use in therapy and limiting research into its potential benefits. Despite the legal obstacles, a dedicated group of researchers and advocates continued to explore the therapeutic potential of MDMA. Organizations like the Multidisciplinary Association for Psychedelic Studies (MAPS) played a crucial role in advancing MDMA research, conducting clinical trials, and advocating for policy changes to facilitate its medical use. To understand how MDMA exerts its therapeutic effects, it's essential to examine its mechanism of action in the brain. MDMA primarily acts on three key neurotransmitter systems: serotonin, dopamine, and norepinephrine. When MDMA enters the brain, it causes a significant release of these neurotransmitters, leading to a cascade of psychological and physiological effects. Serotonin is perhaps the most important neurotransmitter involved in MDMA's action. MDMA causes a massive surge in serotonin levels, which is responsible for the drug's mood-elevating and prosocial effects. This increase in serotonin leads to feelings of euphoria, emotional warmth, and increased empathy. It allows individuals to connect with their emotions and with others in a profound way, which can be particularly beneficial in a therapeutic context. Dopamine, often associated with reward and motivation, is also affected by MDMA. The release of dopamine contributes to the pleasurable and energizing effects of the drug. It can enhance focus and engagement during therapy sessions, helping patients stay present and committed to the therapeutic process. Norepinephrine, a neurotransmitter involved in the body's stress response, is also increased by MDMA. This can lead to some of the physical effects of the drug, such as increased heart rate and blood pressure. However, the release of norepinephrine also plays a role in the emotional impact of MDMA. It can heighten emotional arousal and help individuals access and process difficult emotions. In addition to its effects on these neurotransmitters, MDMA has been shown to increase the release of oxytocin, often referred to as the "love hormone." Oxytocin is involved in social bonding, trust, and emotional regulation. The surge of oxytocin induced by MDMA can create a profound sense of connection and trust between the patient and therapist, fostering a strong therapeutic alliance. The combination of these neurochemical effects creates a unique psychological state characterized by reduced fear and defensiveness, increased empathy and emotional openness, and a heightened capacity for introspection and self-reflection. This state is particularly conducive to therapeutic work, allowing patients to access and process traumatic memories, emotions, and beliefs in a way that may not be possible under normal circumstances. It's important to note that the therapeutic effects of MDMA are not solely due to its pharmacological action. The drug is used as part of a carefully designed therapeutic protocol that includes preparatory sessions, MDMA-assisted sessions, and integrative follow-up sessions. The supportive and safe environment provided by trained therapists is crucial for maximizing the therapeutic potential of MDMA and minimizing the risks associated with its use. The therapeutic applications of MDMA are diverse and far-reaching, with the potential to address a range of mental health conditions. The most well-established and researched application of MDMA is in the treatment of post-traumatic stress disorder (PTSD). PTSD is a debilitating condition that can develop after exposure to a traumatic event, such as combat, sexual assault, or natural disasters. It is characterized by symptoms like intrusive memories, avoidance of trauma-related stimuli, negative alterations in cognition and mood, and hyperarousal. Traditional treatments for PTSD, such as cognitive-behavioral therapy and medication, have limitations and are not effective for everyone. MDMA-assisted psychotherapy has emerged as a promising alternative for individuals with PTSD, particularly those who have not responded to conventional treatments. The unique properties of MDMA, such as reducing fear and increasing empathy, make it well-suited for treating the core symptoms of PTSD. During MDMA-assisted therapy sessions, patients are able to revisit and process traumatic memories in a safe and supportive environment. The drug reduces the fear and emotional numbing associated with these memories, allowing patients to engage with them in a more constructive way. They can access and express emotions that may have been suppressed or avoided, leading to a cathartic release and a new perspective on their experiences. The Multidisciplinary Association for Psychedelic Studies (MAPS) has been at the forefront of research on MDMA-assisted therapy for PTSD. Their clinical trials have yielded impressive results, with a significant proportion of participants experiencing long-lasting improvements in their symptoms. In fact, the results have been so promising that the FDA has granted MDMA-assisted therapy a Breakthrough Therapy designation for PTSD, accelerating its path to approval. A recent article in The New York Times highlighted the anticipation surrounding the FDA's potential approval of MDMA-assisted therapy for PTSD. The article emphasized the transformative potential of this treatment, which could provide relief for the millions of individuals suffering from PTSD worldwide. It also underscored the importance of continued research and responsible use of MDMA in therapeutic settings. While PTSD is currently the primary focus of MDMA therapy research, there is growing interest in exploring its potential for other mental health conditions. Preliminary studies suggest that MDMA could be beneficial for treating depression, anxiety, and social anxiety in autistic adults. Depression, characterized by persistent low mood, loss of interest, and feelings of hopelessness, is a widespread and debilitating mental health condition. Current treatments, such as antidepressant medications and psychotherapy, are not always effective, leaving many individuals struggling with ongoing symptoms. MDMA's ability to promote emotional openness, self-compassion, and insight could make it a valuable tool in the treatment of depression. Similarly, MDMA's prosocial effects and reduction of fear could be particularly useful for individuals with anxiety disorders, including social anxiety disorder. By reducing the emotional barriers that prevent individuals from engaging in social situations, MDMA could facilitate exposure therapy and help individuals develop more adaptive coping strategies. Autism spectrum disorder (ASD) is another area where MDMA therapy shows promise. Many individuals with ASD struggle with social interactions and communication, which can lead to anxiety and isolation. MDMA's ability to enhance empathy and reduce social fears could help autistic adults navigate social situations more effectively and form meaningful connections with others. As research continues to expand, it's likely that new therapeutic applications of MDMA will emerge. The unique properties of this drug, combined with the supportive environment of psychotherapy, hold significant potential for addressing a range of mental health challenges. The resurgence of interest in MDMA as a therapeutic tool has been driven by a growing body of clinical research. In recent years, several landmark clinical trials have provided compelling evidence for the efficacy and safety of MDMA-assisted therapy, particularly for the treatment of PTSD. The most notable clinical trials have been conducted by the Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research and educational organization dedicated to the development of medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics. MAPS has been at the forefront of MDMA research for over three decades, working tirelessly to advance the scientific understanding and clini

MDMA (3,4-methylenedioxymethamphetamine), known commonly as Ecstasy or Molly, has transitioned from a popular recreational drug to a promising therapeutic tool. The unique psychoactive properties of MDMA, which enhance empathy and reduce fear, have made it a powerful aid in psychotherapy, particularly for treating severe psychological conditions like PTSD. This article delves into the historical context, mechanism of action, therapeutic applications, clinical trials, safety considerations, and future prospects of MDMA in therapeutic settings. MDMA has a fascinating history that spans over a century. It was first synthesized by the German pharmaceutical company Merck in 1912 as part of their research into blood-clotting medications. However, the psychoactive properties of MDMA remained unknown for decades. It wasn't until the 1970s that American chemist Alexander Shulgin re-synthesized MDMA in his lab. Shulgin, known for his pioneering work in psychedelic chemistry, recognized the unique effects of MDMA on the human psyche. Shulgin shared his findings with psychotherapist Leo Zeff, who saw the potential of MDMA as a therapeutic aid. Zeff introduced MDMA to the psychotherapy community, where it quickly gained popularity as a tool for facilitating emotional breakthroughs and enhancing the therapeutic alliance. Throughout the late 1970s and early 1980s, MDMA was used by a network of therapists who believed in its ability to catalyze healing. However, MDMA's rising popularity extended beyond therapeutic circles. It became a sought-after recreational drug, particularly in the rave and club scene. The increasing non-medical use of MDMA led to concerns about its potential for abuse and neurotoxicity. In 1985, the U.S. Drug Enforcement Administration (DEA) stepped in and classified MDMA as a Schedule I controlled substance. This classification placed severe restrictions on the legal use of MDMA, effectively halting its use in therapy and limiting research into its potential benefits. Despite the legal obstacles, a dedicated group of researchers and advocates continued to explore the therapeutic potential of MDMA. Organizations like the Multidisciplinary Association for Psychedelic Studies (MAPS) played a crucial role in advancing MDMA research, conducting clinical trials, and advocating for policy changes to facilitate its medical use. To understand how MDMA exerts its therapeutic effects, it's essential to examine its mechanism of action in the brain. MDMA primarily acts on three key neurotransmitter systems: serotonin, dopamine, and norepinephrine. When MDMA enters the brain, it causes a significant release of these neurotransmitters, leading to a cascade of psychological and physiological effects. Serotonin is perhaps the most important neurotransmitter involved in MDMA's action. MDMA causes a massive surge in serotonin levels, which is responsible for the drug's mood-elevating and prosocial effects. This increase in serotonin leads to feelings of euphoria, emotional warmth, and increased empathy. It allows individuals to connect with their emotions and with others in a profound way, which can be particularly beneficial in a therapeutic context. Dopamine, often associated with reward and motivation, is also affected by MDMA. The release of dopamine contributes to the pleasurable and energizing effects of the drug. It can enhance focus and engagement during therapy sessions, helping patients stay present and committed to the therapeutic process. Norepinephrine, a neurotransmitter involved in the body's stress response, is also increased by MDMA. This can lead to some of the physical effects of the drug, such as increased heart rate and blood pressure. However, the release of norepinephrine also plays a role in the emotional impact of MDMA. It can heighten emotional arousal and help individuals access and process difficult emotions. In addition to its effects on these neurotransmitters, MDMA has been shown to increase the release of oxytocin, often referred to as the "love hormone." Oxytocin is involved in social bonding, trust, and emotional regulation. The surge of oxytocin induced by MDMA can create a profound sense of connection and trust between the patient and therapist, fostering a strong therapeutic alliance. The combination of these neurochemical effects creates a unique psychological state characterized by reduced fear and defensiveness, increased empathy and emotional openness, and a heightened capacity for introspection and self-reflection. This state is particularly conducive to therapeutic work, allowing patients to access and process traumatic memories, emotions, and beliefs in a way that may not be possible under normal circumstances. It's important to note that the therapeutic effects of MDMA are not solely due to its pharmacological action. The drug is used as part of a carefully designed therapeutic protocol that includes preparatory sessions, MDMA-assisted sessions, and integrative follow-up sessions. The supportive and safe environment provided by trained therapists is crucial for maximizing the therapeutic potential of MDMA and minimizing the risks associated with its use. The therapeutic applications of MDMA are diverse and far-reaching, with the potential to address a range of mental health conditions. The most well-established and researched application of MDMA is in the treatment of post-traumatic stress disorder (PTSD). PTSD is a debilitating condition that can develop after exposure to a traumatic event, such as combat, sexual assault, or natural disasters. It is characterized by symptoms like intrusive memories, avoidance of trauma-related stimuli, negative alterations in cognition and mood, and hyperarousal. Traditional treatments for PTSD, such as cognitive-behavioral therapy and medication, have limitations and are not effective for everyone. MDMA-assisted psychotherapy has emerged as a promising alternative for individuals with PTSD, particularly those who have not responded to conventional treatments. The unique properties of MDMA, such as reducing fear and increasing empathy, make it well-suited for treating the core symptoms of PTSD. During MDMA-assisted therapy sessions, patients are able to revisit and process traumatic memories in a safe and supportive environment. The drug reduces the fear and emotional numbing associated with these memories, allowing patients to engage with them in a more constructive way. They can access and express emotions that may have been suppressed or avoided, leading to a cathartic release and a new perspective on their experiences. The Multidisciplinary Association for Psychedelic Studies (MAPS) has been at the forefront of research on MDMA-assisted therapy for PTSD. Their clinical trials have yielded impressive results, with a significant proportion of participants experiencing long-lasting improvements in their symptoms. In fact, the results have been so promising that the FDA has granted MDMA-assisted therapy a Breakthrough Therapy designation for PTSD, accelerating its path to approval. A recent article in The New York Times highlighted the anticipation surrounding the FDA's potential approval of MDMA-assisted therapy for PTSD. The article emphasized the transformative potential of this treatment, which could provide relief for the millions of individuals suffering from PTSD worldwide. It also underscored the importance of continued research and responsible use of MDMA in therapeutic settings. While PTSD is currently the primary focus of MDMA therapy research, there is growing interest in exploring its potential for other mental health conditions. Preliminary studies suggest that MDMA could be beneficial for treating depression, anxiety, and social anxiety in autistic adults. Depression, characterized by persistent low mood, loss of interest, and feelings of hopelessness, is a widespread and debilitating mental health condition. Current treatments, such as antidepressant medications and psychotherapy, are not always effective, leaving many individuals struggling with ongoing symptoms. MDMA's ability to promote emotional openness, self-compassion, and insight could make it a valuable tool in the treatment of depression. Similarly, MDMA's prosocial effects and reduction of fear could be particularly useful for individuals with anxiety disorders, including social anxiety disorder. By reducing the emotional barriers that prevent individuals from engaging in social situations, MDMA could facilitate exposure therapy and help individuals develop more adaptive coping strategies. Autism spectrum disorder (ASD) is another area where MDMA therapy shows promise. Many individuals with ASD struggle with social interactions and communication, which can lead to anxiety and isolation. MDMA's ability to enhance empathy and reduce social fears could help autistic adults navigate social situations more effectively and form meaningful connections with others. As research continues to expand, it's likely that new therapeutic applications of MDMA will emerge. The unique properties of this drug, combined with the supportive environment of psychotherapy, hold significant potential for addressing a range of mental health challenges. The resurgence of interest in MDMA as a therapeutic tool has been driven by a growing body of clinical research. In recent years, several landmark clinical trials have provided compelling evidence for the efficacy and safety of MDMA-assisted therapy, particularly for the treatment of PTSD. The most notable clinical trials have been conducted by the Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research and educational organization dedicated to the development of medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics. MAPS has been at the forefront of MDMA research for over three decades, working tirelessly to advance the scientific understanding and clini

MDMA (3,4-methylenedioxymethamphetamine), known commonly as Ecstasy or Molly, has transitioned from a popular recreational drug to a promising therapeutic tool. The unique psychoactive properties of MDMA, which enhance empathy and reduce fear, have made it a powerful aid in psychotherapy, particularly for treating severe psychological conditions like PTSD. This article delves into the historical context, mechanism of action, therapeutic applications, clinical trials, safety considerations, and future prospects of MDMA in therapeutic settings. MDMA has a fascinating history that spans over a century. It was first synthesized by the German pharmaceutical company Merck in 1912 as part of their research into blood-clotting medications. However, the psychoactive properties of MDMA remained unknown for decades. It wasn't until the 1970s that American chemist Alexander Shulgin re-synthesized MDMA in his lab. Shulgin, known for his pioneering work in psychedelic chemistry, recognized the unique effects of MDMA on the human psyche. Shulgin shared his findings with psychotherapist Leo Zeff, who saw the potential of MDMA as a therapeutic aid. Zeff introduced MDMA to the psychotherapy community, where it quickly gained popularity as a tool for facilitating emotional breakthroughs and enhancing the therapeutic alliance. Throughout the late 1970s and early 1980s, MDMA was used by a network of therapists who believed in its ability to catalyze healing. However, MDMA's rising popularity extended beyond therapeutic circles. It became a sought-after recreational drug, particularly in the rave and club scene. The increasing non-medical use of MDMA led to concerns about its potential for abuse and neurotoxicity. In 1985, the U.S. Drug Enforcement Administration (DEA) stepped in and classified MDMA as a Schedule I controlled substance. This classification placed severe restrictions on the legal use of MDMA, effectively halting its use in therapy and limiting research into its potential benefits. Despite the legal obstacles, a dedicated group of researchers and advocates continued to explore the therapeutic potential of MDMA. Organizations like the Multidisciplinary Association for Psychedelic Studies (MAPS) played a crucial role in advancing MDMA research, conducting clinical trials, and advocating for policy changes to facilitate its medical use. To understand how MDMA exerts its therapeutic effects, it's essential to examine its mechanism of action in the brain. MDMA primarily acts on three key neurotransmitter systems: serotonin, dopamine, and norepinephrine. When MDMA enters the brain, it causes a significant release of these neurotransmitters, leading to a cascade of psychological and physiological effects. Serotonin is perhaps the most important neurotransmitter involved in MDMA's action. MDMA causes a massive surge in serotonin levels, which is responsible for the drug's mood-elevating and prosocial effects. This increase in serotonin leads to feelings of euphoria, emotional warmth, and increased empathy. It allows individuals to connect with their emotions and with others in a profound way, which can be particularly beneficial in a therapeutic context. Dopamine, often associated with reward and motivation, is also affected by MDMA. The release of dopamine contributes to the pleasurable and energizing effects of the drug. It can enhance focus and engagement during therapy sessions, helping patients stay present and committed to the therapeutic process. Norepinephrine, a neurotransmitter involved in the body's stress response, is also increased by MDMA. This can lead to some of the physical effects of the drug, such as increased heart rate and blood pressure. However, the release of norepinephrine also plays a role in the emotional impact of MDMA. It can heighten emotional arousal and help individuals access and process difficult emotions. In addition to its effects on these neurotransmitters, MDMA has been shown to increase the release of oxytocin, often referred to as the "love hormone." Oxytocin is involved in social bonding, trust, and emotional regulation. The surge of oxytocin induced by MDMA can create a profound sense of connection and trust between the patient and therapist, fostering a strong therapeutic alliance. The combination of these neurochemical effects creates a unique psychological state characterized by reduced fear and defensiveness, increased empathy and emotional openness, and a heightened capacity for introspection and self-reflection. This state is particularly conducive to therapeutic work, allowing patients to access and process traumatic memories, emotions, and beliefs in a way that may not be possible under normal circumstances. It's important to note that the therapeutic effects of MDMA are not solely due to its pharmacological action. The drug is used as part of a carefully designed therapeutic protocol that includes preparatory sessions, MDMA-assisted sessions, and integrative follow-up sessions. The supportive and safe environment provided by trained therapists is crucial for maximizing the therapeutic potential of MDMA and minimizing the risks associated with its use. The therapeutic applications of MDMA are diverse and far-reaching, with the potential to address a range of mental health conditions. The most well-established and researched application of MDMA is in the treatment of post-traumatic stress disorder (PTSD). PTSD is a debilitating condition that can develop after exposure to a traumatic event, such as combat, sexual assault, or natural disasters. It is characterized by symptoms like intrusive memories, avoidance of trauma-related stimuli, negative alterations in cognition and mood, and hyperarousal. Traditional treatments for PTSD, such as cognitive-behavioral therapy and medication, have limitations and are not effective for everyone. MDMA-assisted psychotherapy has emerged as a promising alternative for individuals with PTSD, particularly those who have not responded to conventional treatments. The unique properties of MDMA, such as reducing fear and increasing empathy, make it well-suited for treating the core symptoms of PTSD. During MDMA-assisted therapy sessions, patients are able to revisit and process traumatic memories in a safe and supportive environment. The drug reduces the fear and emotional numbing associated with these memories, allowing patients to engage with them in a more constructive way. They can access and express emotions that may have been suppressed or avoided, leading to a cathartic release and a new perspective on their experiences. The Multidisciplinary Association for Psychedelic Studies (MAPS) has been at the forefront of research on MDMA-assisted therapy for PTSD. Their clinical trials have yielded impressive results, with a significant proportion of participants experiencing long-lasting improvements in their symptoms. In fact, the results have been so promising that the FDA has granted MDMA-assisted therapy a Breakthrough Therapy designation for PTSD, accelerating its path to approval. A recent article in The New York Times highlighted the anticipation surrounding the FDA's potential approval of MDMA-assisted therapy for PTSD. The article emphasized the transformative potential of this treatment, which could provide relief for the millions of individuals suffering from PTSD worldwide. It also underscored the importance of continued research and responsible use of MDMA in therapeutic settings. While PTSD is currently the primary focus of MDMA therapy research, there is growing interest in exploring its potential for other mental health conditions. Preliminary studies suggest that MDMA could be beneficial for treating depression, anxiety, and social anxiety in autistic adults. Depression, characterized by persistent low mood, loss of interest, and feelings of hopelessness, is a widespread and debilitating mental health condition. Current treatments, such as antidepressant medications and psychotherapy, are not always effective, leaving many individuals struggling with ongoing symptoms. MDMA's ability to promote emotional openness, self-compassion, and insight could make it a valuable tool in the treatment of depression. Similarly, MDMA's prosocial effects and reduction of fear could be particularly useful for individuals with anxiety disorders, including social anxiety disorder. By reducing the emotional barriers that prevent individuals from engaging in social situations, MDMA could facilitate exposure therapy and help individuals develop more adaptive coping strategies. Autism spectrum disorder (ASD) is another area where MDMA therapy shows promise. Many individuals with ASD struggle with social interactions and communication, which can lead to anxiety and isolation. MDMA's ability to enhance empathy and reduce social fears could help autistic adults navigate social situations more effectively and form meaningful connections with others. As research continues to expand, it's likely that new therapeutic applications of MDMA will emerge. The unique properties of this drug, combined with the supportive environment of psychotherapy, hold significant potential for addressing a range of mental health challenges. The resurgence of interest in MDMA as a therapeutic tool has been driven by a growing body of clinical research. In recent years, several landmark clinical trials have provided compelling evidence for the efficacy and safety of MDMA-assisted therapy, particularly for the treatment of PTSD. The most notable clinical trials have been conducted by the Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research and educational organization dedicated to the development of medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics. MAPS has been at the forefront of MDMA research for over three decades, working tirelessly to advance the scientific understanding and clini

MDMA Therapy

Beril'le hayatın içinden kimya diliyle.
Her hafta yeni bölüm!
instagram: @berilsenakaya

Beril'le hayatın içinden kimya diliyle. Her hafta yeni bölüm! instagram: @berilsenakaya

Kimyasal Sohbetler

Magazine dedicato a medicina, ricerca e benessere con interviste a medici ed esperti su prevenzione, innovazione e buone abitudini per la salute.

Salute Magazine

Originally these episodes were recorded for our one-hour weekly radio show, airing on 101.7 FM in Richmond, VA. That format didn't allow for folks to hear it unless they caught it live, and we have built the library of them so everyone can listen at their leisure. The content is designed for our local water but applies to most of the US.&nbsp; We discuss private well, community well, and municipal water supplies as well as common contaminants found in each. Some examples are: Chlorine, Chloramine, Hardness, Silica, Manganese, Iron, Pathogens, PH and TDS, but we continue to expand our content as we see new problems. if yo want to hear about anything specific, please comment or visit our website at KineticoRichmond.com!

Originally these episodes were recorded for our one-hour weekly radio show, airing on 101.7 FM in Richmond, VA. That format didn't allow for folks to hear it unless they caught it live, and we have built the library of them so everyone can listen at their leisure. The content is designed for our local water but applies to most of the US.  We discuss private well, community well, and municipal water supplies as well as common contaminants found in each. Some examples are: Chlorine, Chloramine, Hardness, Silica, Manganese, Iron, Pathogens, PH and TDS, but we continue to expand our content as we see new problems. if yo want to hear about anything specific, please comment or visit our website at KineticoRichmond.com!

Water Guy Unfiltered

Podcast educativo sobre Ciencias, matemática, química y física.

La tabla periódica y los elementos

A special segment on Money FM 89.3's Breakfast Show that brings you on an exclusive audio journey to the ends of the world, covering in-depth environment, natural history and climate change stories that intertwine with human life on Earth.

A special segment on Money FM 89.3's Breakfast Show that brings you on an exclusive audio journey to the ends of the world, covering in-depth environment, natural history and climate change stories that intertwine with human life on Earth.

Climate Connections

Temas opo

Explicando as funções inorgânicas

for my alex

Prozessindustrie und Nachhaltigkeit sind keinesfalls Gegensätze, sondern zwei Seiten der gleichen Medaille. Sie ergänzen, ja sie bedingen sich vielfach. Was treibt die Verantwortlichen derzeit um? Im PROCESS-Podcast GreenTEC gehen wir dem auf den Grund und zeigen innovative, grüne Lösungen für eine nachhaltige Zukunft der Branche.

GreenTEC

The VirtualPharm Podcast is an audio series that covers topics related to compliance and regulatory affairs in the Lifesciences industry. Each episode, hosted by experts on the topic with decades of experience, offers listeners detailed insight into the changing regulatory environment. The podcast provides timely information about emerging regulations, legal updates, industry insights, and best practices for organizations. The episodes are informative and engaging, helping educate professionals on remaining compliant while staying agile in their industry.

The VirtualPharm Podcast is an audio series that covers topics related to compliance and regulatory affairs in the Lifesciences industry. Each episode, hosted by experts on the topic with decades of experience, offers listeners detailed insight into the changing regulatory environment. The podcast provides timely information about emerging regulations, legal updates, industry insights, and best practices for organizations. The episodes are informative and engaging, helping educate professionals on remaining compliant while staying agile in their industry.

The VirtualPharm

El podcast del Instituto de Nanociencia y Materiales de Aragón que te acerca las historias detrás de la investigación en Nanociencia y Ciencia de Materiales de la mano de sus protagonistas.

En Materia

Southeast Asia is highly interconnected, so it’s easy to move between countries by bus, train, or budget airlines. Some popular routes include Thailand to Cambodia and Vietnam to Laos.

Southeast Asia is highly interconnected, so it’s easy to move between countries by bus, train, or budget airlines. Some popular routes include Thailand to Cambodia and Vietnam to Laos.

Backpacking through Southeast Asia

On Lubrication Experts, Rafe Britton talk with the best in the business about all things lubricants, engineering and industry. From lubricant technology and condition monitoring to supply chain and manufacturing the experts sit down to give their take on the current and future states of the industry.

Lubrication Experts

Podcast Topic: Chemistry Title: "Chemistry Unveiled: The Magic Behind the Molecules" Description:Dive into the fascinating world of chemistry with "Chemistry Unveiled: The Magic Behind the Molecules." This podcast unravels the mysteries of the elements that make up our universe, exploring everything from the tiniest atoms to the vast complexities of chemical reactions. Whether you're a science enthusiast, a student, or simply curious about the world around you, join us as we break down complex concepts into easy-to-understand episodes, share exciting stories from the history of chemistry, and interview leading experts in the field. Get ready to ignite your curiosity and see the world through the lens of chemistry, where every episode promises to be a thrilling journey of discovery.

Podcast Topic: Chemistry Title: "Chemistry Unveiled: The Magic Behind the Molecules" Description: Dive into the fascinating world of chemistry with "Chemistry Unveiled: The Magic Behind the Molecules." This podcast unravels the mysteries of the elements that make up our universe, exploring everything from the tiniest atoms to the vast complexities of chemical reactions. Whether you're a science enthusiast, a student, or simply curious about the world around you, join us as we break down complex concepts into easy-to-understand episodes, share exciting stories from the history of chemistry, and interview leading experts in the field. Get ready to ignite your curiosity and see the world through the lens of chemistry, where every episode promises to be a thrilling journey of discovery.

HR chemistry talks

Chemistry as a discipline has a reputation to the public of being boring, hard to understand, and dry. However, there are both people and experiments that changed history. We will cover laboratory and industrial accidents, cases of fraud like Jan Hendrik Schön, and the man that has caused more harm to earth’s atmosphere than any other single organism Thomas Midgley Jr. We will talk about the greatest chemists and their lives from Marie Curie to Rosalind Franklin to Neils Bohr to Glenn Seaborg. The Chemistry of everyday things like medications, tattoo ink, soaps and cleaners, cosmetics, sunscreen, and more! Join us for Cowboy Chemistry!

Cowboy Chemistry

BLAHHHtesting

Chartable Feed Testing

Lecture-casts- A Podcast Lecture-Series on General Chemistry. Please note the views of this podcast represent those of my guest(s) and I.

Lecture-casts- A Podcast Lecture-Series on General Chemistry. Please note the views of this podcast represent those of my guest(s) and I.

"Lecture-casts"- A Lecture Series on General Chemistry

Each podcast contains timely nutritional information from Adisseo and industry experts.&nbsp; &nbsp; The conversational Transition Health series focuses on solutions to transition health concerns.&nbsp; &nbsp; The previous two series present research highlights from the 2021 and 2022 American Dairy Science Association (ADSA) Annual Meetings.&nbsp; &nbsp; The latest serie focuses on Amino Acid balancing for Lifetime Performance as we are celebrating the 30th anniversary of AA balancing in 2023.

Each podcast contains timely nutritional information from Adisseo and industry experts.    The conversational Transition Health series focuses on solutions to transition health concerns.    The previous two series present research highlights from the 2021 and 2022 American Dairy Science Association (ADSA) Annual Meetings.    The latest serie focuses on Amino Acid balancing for Lifetime Performance as we are celebrating the 30th anniversary of AA balancing in 2023.

Smart Science Series™ Ruminant Podcasts

En ConCiencia hablaremos de una manera amena sobre los productos de Polioles, aplicaciones, tendencias en el mercado y avances en la industria química; teniendo como invitados a diferentes expertos en el tema.Quédate y reta a tu mente para crear ConCiencia.Polioles es una empresa petroquímica dedicada a la fabricación y comercialización de productos químicos con una trayectoria de más de 55 años en el mercado. Síguenos en <a href="https://www.linkedin.com/company/poliolesmx/about/" rel="nofollow">LinkedIn</a> y si tienes dudas comunícate con nosotros.Para mayor información pueden ingresar a nuestra página web.<a href="http://polioles.com.mx" rel="nofollow">http://polioles.com.mx</a>Produced by <a href="ELLUCHADOR.AUDIO/SERVICES" rel="nofollow">El Luchador Audio</a>

En ConCiencia hablaremos de una manera amena sobre los productos de Polioles, aplicaciones, tendencias en el mercado y avances en la industria química; teniendo como invitados a diferentes expertos en el tema.Quédate y reta a tu mente para crear ConCiencia. Polioles es una empresa petroquímica dedicada a la fabricación y comercialización de productos químicos con una trayectoria de más de 55 años en el mercado. Síguenos en LinkedIn y si tienes dudas comunícate con nosotros. Para mayor información pueden ingresar a nuestra página web. http://polioles.com.mx Produced by El Luchador Audio

En ConCiencia hablaremos de una manera amena sobre los productos de Polioles, aplicaciones, tendencias en el mercado y avances en la industria química; teniendo como invitados a diferentes expertos en el tema.Quédate y reta a tu mente para crear ConCiencia.Polioles es una empresa petroquímica dedicada a la fabricación y comercialización de productos químicos con una trayectoria de más de 55 años en el mercado. Síguenos en <a href="https://www.linkedin.com/company/poliolesmx/about/" rel="noopener noreferrer">LinkedIn</a> y si tienes dudas comunícate con nosotros.Para mayor información pueden ingresar a nuestra página web.<a href="http://polioles.com.mx" rel="noopener noreferrer">http://polioles.com.mx</a>Produced by <a href="ELLUCHADOR.AUDIO/SERVICES" rel="noopener noreferrer">El Luchador Audio</a>

Polioles ConCiencia

&#34;Holy Podcasting, Batman!&#34;

Pod Forbid 🙏

Intensificación de procesos químicos y bioquímicos para la valorización de productos y servicios bajo un modelo sostenible de economía circular busca establecer alternativas para la intensificación de procesos químicos y bioquímicos para la valorización de productos y servicios bajo un modelo sostenible de economía circular.

Economía circular: química y bioquímica

בשנים האחרונות קמה לנו תעשייה חדשה מתחת לאף- תעשיית הפודטק. 
פודקאסט &quot;FoodTech Nation&quot; מספר לכם את מאחורי הקלעים של עולם הפודטק בישראל, שיחות עם גדולים מהתעשייה &#8211; יזמים, משקיעים ועוד, הכל על מנת לענות על השאלה &#8211; כיצד תראה הצלחת שלנו בעתיד הקרוב?

בשנים האחרונות קמה לנו תעשייה חדשה מתחת לאף- תעשיית הפודטק. פודקאסט "FoodTech Nation" מספר לכם את מאחורי הקלעים של עולם הפודטק בישראל, שיחות עם גדולים מהתעשייה – יזמים, משקיעים ועוד, הכל על מנת לענות על השאלה – כיצד תראה הצלחת שלנו בעתיד הקרוב?

בשנים האחרונות קמה לנו תעשייה חדשה מתחת לאף- תעשיית הפודטק. 
פודקאסט "FoodTech Nation" מספר לכם את מאחורי הקלעים של עולם הפודטק בישראל, שיחות עם גדולים מהתעשייה – יזמים, משקיעים ועוד, הכל על מנת לענות על השאלה – כיצד תראה הצלחת שלנו בעתיד הקרוב?

Chemistry Podcasts / Page 14